DermaSensor Resources

Read Now

Publications

Clinical Registry Case Study: Assessing the Impact of Integrating DermaSensor™ into Primary Care for Skin Cancer ManagementMarcy Goisse, MD; Betty Thomas, MD. Montgomery Medical, Inc., Smithfield and Brownsville, PA

The DermaSensor DeviceDermaSensor is a validated, FDA-cleared handheld device that non-invasively evaluates skin lesions forcancer. It captures spectral samples of a lesion and, using a proprietary algorithm, classifies the lesion’sspectral properties against those of known malignant and benign lesions. Real-World Impact: More Cancers Detected, with Greater Diagnostic EfficiencyDrs. Goisse and Thomas reviewed skin-lesion data and […]

Read Now

Publications

Summary of DermaSensor Device Safety and Effectiveness Results From Three Clinical Studies

FDA Cleared

Read Now

Publications

Validation of a Handheld Elastic Scattering Spectroscopy Device on Lesions Concerning for Melanoma 

Introduction and Objectives Skin cancer is the most common cancer worldwide and its most common types are basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma [1,2]. One in five Americans will develop skin cancer by the age of 70 and more than two people die of skin cancer in the U.S. every hour […]

Read Now

Publications

Clinical Utility of an Elastic Scattering Spectroscopy Device in Assisting Primary Care Physicians’ Detection of Skin Cancers

Background and Objective Access to a dermatologist for diagnosis and management of skin cancer is challenging, as around 40% of the United States population live in areas that have limited access to a dermatologist [1]. This puts primary care physicians (PCPs) in an integral role for early detection of skin cancers, as early detection of […]

Read Now

Publications

Clinical Performance of Novel Elastic Scattering Spectroscopy (ESS) in Detection of Skin Cancer: A Blinded, Prospective, Multi-Center Clinical Trial

Stephen P Merry, MD1; Brian McCormick, MD2; Vivien Nguyen PharmD4, Kiran Chatha, MD, MPH4; Ivana Croghan, PhD1,, David Leffell, MD3 1 Mayo Clinic, Rochester, MD; 2 Hampton Family Practice, Hampton, VA; 3 Yale School of Medicine, New Haven, CT; 4 DermaSensor Inc. FDA Cleared.Available in the United States. Background and Objective Skin cancer is by far the most common type of cancer […]

Read Now

Publications

DermaSensor Product Brochure

Better decisions, better detection, more accurate management DermaSensor empowers physicians by providing objective, actionable risk results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically. Features Indications for use The DermaSensor™ device is indicated for evaluating skin lesions suggestive of melanoma, basal cell carcinoma, and/or […]

Read Now

Publications

Publications 2025

Read Now

Publications

Publications 2025, Sage Journals: Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer

Read Now

Publications

Publications 2025, Sage Journals: DERM-SUCCESS FDA Pivotal Study: A Multi-Reader Multi-Case Evaluation of Primary Care Physicians’ Skin Cancer Detection Using AI-Enabled Elastic Scattering Spectroscopy